- FTC Staff Opinion with Respect to Doylestown Health Physicians ( )
- Public Access to Illumina/Grail Trial Provided via Teleconference Due to ongoing COVID-19 Concerns ( )
- Statement of FTC Office of Public Affairs Director Lindsay Kryzak on District Court’s Decision to Grant Preliminary Injunction Halting New Jersey Hospital Merger ( )
- Refunds Coming to Consumers Who Bought Deceptively Marketed Willow Curve Device ( )
- Federal Trade Commission Withdraws Remaining Case against AbbVie after Supreme Court Decision Strips Consumers of Relief ( )
- FTC Finalizes Order with Flo Health, a Fertility-Tracking App that Shared Sensitive Health Data with Facebook, Google, and Others ( )
- Promoter of $23,000 COVID-19 “Treatment” Plan Barred from Making Bogus Health Claims ( )
- Federal Trade Commission Sends Report to Congress on Rebate Walls ( )
- Statement of FTC Acting Bureau of Competition Director Maribeth Petrizzi on Bureau’s Motion to Dismiss Request for Preliminary Relief in Illumina/GRAIL Case ( )
- Multilateral Pharmaceutical Merger Task Force Seeks Public Input ( )
- FTC Returns Nearly $60 Million to Those Suffering from Opioid Addiction Who Were Allegedly Overcharged in Suboxone Film Scheme ( )
- U.S. Court of Appeals for the Fifth Circuit Upholds FTC’s Opinion against Generic Pharmaceutical Company Impax Laboratories, LLC ( )
- FTC Challenges Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail ( )
- Acting FTC Chairwoman Releases 2020 Annual Highlights ( )
- FTC Announces Multilateral Working Group to Build a New Approach to Pharmaceutical Mergers ( )
- Following Federal Trade Commission Staff Recommendation to Challenge Transaction, Two Health Care Systems in Central Georgia Abandon Proposed Merger ( )
- FTC Gives Final Approval to Settlement with Emergency Travel Services Provider Related to Allegations It Failed to Secure Sensitive Data ( )
- FTC Again Charges Endo and Impax with Illegally Preventing Competition in U.S. Market for Oxymorphone ER ( )
- FTC Comment to Department of Veterans Affairs Supports Agency’s Interim Final Rule on VA Professionals’ Authority to Practice Health Care ( )
- FTC to Study the Impact of Physician Group and Healthcare Facility Mergers ( )
- Developer of Popular Women’s Fertility-Tracking App Settles FTC Allegations that It Misled Consumers About the Disclosure of their Health Data ( )
- Statement of Daniel Francis, Deputy Director of the FTC’s Bureau of Competition, Regarding the Announcement that Methodist Le Bonheur Healthcare has Abandoned Its Proposed Acquisition of Two Memphis-area Hospitals from Tenet Healthcare ( )
- FTC Approves Final Order Imposing Conditions on Stryker Corp.’s Acquisition of Wright Medical Group N.V. ( )
- Company that Provides Travel Emergency Services Settles FTC Allegations it Failed to Secure Sensitive Consumer Data ( )
- FTC Sends 28 Warning Letters Regarding Agency’s Eyeglass Rule ( )
- FTC Challenges Hackensack Meridian Health, Inc.’s Proposed Acquisition of Competitor Englewood Healthcare Foundation ( )
- FTC Approves Otto Bock HealthCare North America, Inc.’s Application to Divest Assets It Gained through Acquisition of FIH Group Holdings, LLC ( )
- FTC Sues to Block Proposed Acquisition of Two Memphis-Area Hospitals ( )
- FTC Requires Medical Device Companies Stryker Corp. and Wright Medical Group N.V. to Divest Assets to Preserve Competition ( )
- FTC Requests Public Comment on Otto Bock HealthCare North America, Inc.’s Application to Approve Divestiture of Assets It Gained through Acquisition of FIH Group Holdings, LLC ( )
El .gov significa que es oficial.
Los sitios web del gobierno federal siempre usan un dominio .gov o .mil. Antes de compartir información confidencial en línea, asegúrese de estar en un sitio .gov o .mil.
Este sitio es seguro.
El https:// medios todos los datos transmitidos son cifrados - en otras palabras, cualquier información o el historial de navegación que proporcione se transmite de forma segura.